Corbus Pharmaceuticals Holdings (CRBP) EPS (Basic) (2013 - 2025)
Corbus Pharmaceuticals Holdings' (CRBP) quarterly EPS (Basic) came in at -$1.98 in Q3 2025, down 31.66% year-on-year from -$2.9 in Q3 2024, and down 1948.13% quarter-over-quarter from $0.11 in Q2 2025.
Corbus Pharmaceuticals Holdings (CRBP) EPS (Basic) (2013 - 2025) Analysis & Trends
Corbus Pharmaceuticals Holdings' EPS (Basic) history runs 13 years deep, the most recent figure standing at -$1.98 for Q3 2025.
- On a quarterly basis, EPS (Basic) fell 31.66% year-over-year to -$1.98 in Q3 2025; TTM through Dec 2025 was -$1.99, a 44.69% increase from a year earlier, with the FY2024 full-year figure at $0.32, up 100.99% from the prior year.
- EPS (Basic) eased to -$1.98 in Q3 2025 per CRBP's latest filing, from $0.11 in the prior quarter.
- Across five years, EPS (Basic) topped out at $0.17 in Q4 2024 and bottomed at -$13.91 in Q2 2021.
- The 5-year median for EPS (Basic) is -$2.54 (2022), against an average of -$4.38.
- Across the five-year window, EPS (Basic) jumped 106.85% in 2024 and tumbled 589.72% in 2025, its largest moves.
- Year by year, EPS (Basic) stood at -$2.55 in 2021, then advanced by 0.4% to -$2.54 in 2022, then gained by 2.24% to -$2.48 in 2023, then soared by 106.85% to $0.17 in 2024, then slumped by 1269.31% to -$1.98 in 2025.
- Per Business Quant, the three latest CRBP EPS (Basic) figures stand at -$1.98 (Q3 2025), $0.11 (Q2 2025), and -$0.11 (Q1 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.16 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 0.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 0.00 |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -2.29 |
| 10 | Corbus Pharmaceuticals Holdings | 164.14 Mn | 136.33 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -1.98 |
| Jun 30, 2025 | 0.11 |
| Mar 31, 2025 | -0.11 |
| Dec 31, 2024 | 0.17 |
| Sep 30, 2024 | -1.51 |
| Jun 30, 2024 | -2.10 |
| Mar 31, 2024 | 0.02 |
| Dec 31, 2023 | -2.48 |
| Sep 30, 2023 | -6.85 |
| Jun 30, 2023 | -6.77 |
| Mar 31, 2023 | -4.36 |
| Dec 31, 2022 | -2.54 |
| Sep 30, 2022 | -4.59 |
| Jun 30, 2022 | -5.55 |
| Mar 31, 2022 | -2.20 |
| Dec 31, 2021 | -2.55 |
| Sep 30, 2021 | -12.62 |
| Jun 30, 2021 | -13.91 |
| Mar 31, 2021 | -13.35 |
| Dec 31, 2020 | -8.06 |